Free Trial

Emergent Biosolutions (EBS) Insider Trading & Ownership

Emergent Biosolutions logo
$9.13 +0.08 (+0.93%)
Closing price 05/6/2026 03:59 PM Eastern
Extended Trading
$9.01 -0.13 (-1.38%)
As of 05/6/2026 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Emergent Biosolutions (NYSE:EBS) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
6.00%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
6
Amount Of
Insider Selling
(Last 12 Months)
$1.27M
Get EBS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Emergent Biosolutions stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

EBS Insider Buying and Selling by Quarter

Emergent Biosolutions Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/1/2026Sell15,481$8.40$130,040.40  
5/1/2026Sell17,202$8.40$144,496.80  
5/1/2026Sell13,761$8.40$115,592.40  
4/30/2026
Keith Katkin
Keith Katkin
Director
Sell15,481$8.28$128,182.68  
12/5/2025Sell21,984$11.97$263,148.48  
10/7/2025Sell30,608$10.00$306,080.00  
8/15/2025Sell7,086$8.87$62,852.82  
8/12/2025Sell7,844$8.65$67,850.60  
5/23/2025
Keith Katkin
Keith Katkin
Director
Sell7,844$6.30$49,417.20  
(Data available from 1/1/2013 forward)

EBS Insider Trading Activity - Frequently Asked Questions

6.00% of Emergent Biosolutions stock is owned by insiders. Learn more on EBS's insider holdings.

The following insiders have sold EBS shares in the last 24 months: Coleen Glessner ($306,080.00), Donald W Degolyer ($197,891.00), Kathryn C Zoon ($283,180.34), Keith Katkin ($177,599.88), Neal Franklin Fowler ($204,050.00), Ronald Richard ($263,148.48), and Sujata Tyagi Dayal ($115,592.40).

Insiders have sold a total of 185,210 Emergent Biosolutions shares in the last 24 months for a total of $1,547,542.10 sold.



This page (NYSE:EBS) was last updated on 5/7/2026 by MarketBeat.com Staff.
From Our Partners